Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer (CRPC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02001623
What this trial is testing

Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors

Who this might be right for
Ovary CancerCervix CancerEndometrium Cancer+5 more
Seagen Inc. 195
Testing effectiveness (Phase 2)Study completedNCT01270880
What this trial is testing

Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
Barbara Ann Karmanos Cancer Institute 18
Early research (Phase 1)Ended earlyNCT00933426
What this trial is testing

Lenalidomide and Paclitaxel in Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT01688492
What this trial is testing

Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 54
Testing effectiveness (Phase 2)Ended earlyNCT01469338
What this trial is testing

Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel

Who this might be right for
DiarrheaHormone-resistant Prostate CancerRecurrent Prostate Cancer+5 more
University of Southern California 9
Not applicableStudy completedNCT02141438
What this trial is testing

Observational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Bayer 1,472
Early research (Phase 1)Looking for participantsNCT06683066
What this trial is testing

Study on Human Bioequivalence of Triprerelin Acetate for Injection

Who this might be right for
Prostate Cancer (CRPC)
The Affiliated Hospital of Qingdao University 120
Not applicableUnknownNCT04188275
What this trial is testing

CIRCULATING MICRO-RNA (miRNA) AND AR-V7 MUTATIONAL STATUS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC): PRIMERA+ STUDY (PROSTATE CANCER INNOVATING MARKERS OF EXPECTED RESPONSE TO AGONIST LHRH+ ANDROGEN RECEPTOR INHIBITION

Who this might be right for
D011471D064129D035683+2 more
Azienda Ospedaliero-Universitaria Careggi 46
Testing effectiveness (Phase 2)Study completedNCT00976755
What this trial is testing

Everolimus as First-Line Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Swiss Cancer Institute 37
Early research (Phase 1)Study completedNCT03123978
What this trial is testing

Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer
University of California, Davis 6
Testing effectiveness (Phase 2)UnknownNCT00684970
What this trial is testing

Phase IIB Clinical Trial of Hamsa-1™ in Metastatic Castration Resistant Prostate Cancer (CRPC)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (CRPC)
Tiltan Pharma Ltd. 100
Testing effectiveness (Phase 2)Study completedNCT01834651
What this trial is testing

A Phase II Study of Cabozantinib (XL184) Therapy in Castrate Resistant Prostate Cancer (CRPC) With Visceral Metastases

Who this might be right for
Prostate Cancer
Edwin Posadas, MD 17
Testing effectiveness (Phase 2)Study completedNCT02346578
What this trial is testing

Comparative Study of Alternative Antiandrogen (AA) Therapy and Early Initiating of Enzalutamide for Castration-resistant Prostate Cancer (CRPC) After Combined Androgen Blockade (CAB) Therapy.

Who this might be right for
Castration-resistant Prostate Cancer
Taro Iguchi, MD, PHD 104
Testing effectiveness (Phase 2)Study completedNCT02034552
What this trial is testing

Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC)

Who this might be right for
Prostatic Neoplasms
Bayer 68
Very early researchStudy completedNCT02113657
What this trial is testing

T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Ended earlyNCT02378870
What this trial is testing

A Phase IIb Study to Evaluate Efficacy and Tolerability of ODX (Osteodex) in Metastatic CRPC

Who this might be right for
Prostate Cancer Metastatic
DexTech Medical AB 3
Testing effectiveness (Phase 2)Ended earlyNCT03330405
What this trial is testing

Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors

Who this might be right for
Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors
Pfizer 223
Early research (Phase 1)Study completedNCT01497925
What this trial is testing

Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer

Who this might be right for
Solid TumorsProstate Cancer
Polaris Group 43
Not applicableStudy completedNCT02135484
What this trial is testing

Radium 223 in Castrate Resistant Prostate Cancer Bone Metastases

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 27
Testing effectiveness (Phase 2)Ended earlyNCT02685267
What this trial is testing

Docetaxel/Prednisone Versus Docetaxel/Prednisone and Enzalutamide in Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Prostate Cancer Clinical Trials Consortium 9
Next Page